We are live on ! Find out more
ROIV icon

Roivant Sciences
ROIV

42 hedge funds and large institutions have $3.42B invested in Roivant Sciences in 2021 Q4 according to their latest regulatory filings, with 42 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

49.54% more ownership

Funds ownership: 0% → 49.54% (+50%)

Holders
42
Holders Change
+42
Holders Change %
–
% of All Funds
0.65%
Holding in Top 10
7
Holding in Top 10 Change
+7
Holding in Top 10 Change %
% of All Funds
0.11%
New
42
Increased
–
Reduced
–
Closed
–
Calls
$504K
Puts
–
Net Calls
+$504K
Net Calls Change
+$504K

Top Buyers

Rank Fund Capital Flow
1
QF
QVT Financial
New York
+$1.08B
2
SIAU
SB Investment Advisers (UK)
United Kingdom
+$827M
3
Viking Global Investors
Viking Global Investors
Connecticut
+$734M
4
HH
HSG Holding
Hong Kong
+$41.2M
5
BlackRock
BlackRock
New York
+$32.7M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
QF
1
QVT Financial
New York
$1.3B +$1.08B +129,393,817 New
SIAU
2
SB Investment Advisers (UK)
United Kingdom
$1B +$827M +99,375,586 New
Viking Global Investors
3
Viking Global Investors
Connecticut
$889M +$734M +88,238,700 New
HH
4
HSG Holding
Hong Kong
$49.9M +$41.2M +4,953,984 New
BlackRock
5
BlackRock
New York
$39.6M +$32.7M +3,927,090 New
PT
6
Palantir Technologies
Colorado
$30.2M +$25M +3,000,000 New
Fidelity Investments
7
Fidelity Investments
Massachusetts
$25.2M +$20.8M +2,500,000 New
Geode Capital Management
8
Geode Capital Management
Massachusetts
$11.7M +$9.65M +1,160,137 New
Vanguard Group
9
Vanguard Group
Pennsylvania
$11.7M +$9.65M +1,159,712 New
FFVM
10
Founders Fund VI Management
California
$9.1M +$9.31M +1,119,489 New
RI
11
RTW Investments
New York
$8.09M +$6.68M +802,717 New
Charles Schwab
12
Charles Schwab
California
$6.97M +$5.75M +691,080 New
SCM
13
Suvretta Capital Management
New York
$6.87M +$5.67M +681,528 New
EAM
14
Eventide Asset Management
Massachusetts
$6.7M +$5.82M +700,000 New
PIM
15
Platinum Investment Management
Australia
$3.26M +$2.69M +323,643 New
TSC
16
Two Seas Capital
New York
$3.13M +$2.59M +311,045 New
State Street
17
State Street
Massachusetts
$2.94M +$2.43M +291,800 New
Northern Trust
18
Northern Trust
Illinois
$1.7M +$1.4M +168,344 New
PVI
19
Pura Vida Investments
New York
$1.05M +$869K +104,413 New
CS
20
Credit Suisse
Switzerland
$530K +$437K +52,542 New
PCM
21
Penserra Capital Management
California
$484K +$400K +48,050 New
Bank of New York Mellon
22
Bank of New York Mellon
New York
$433K +$357K +42,939 New
Renaissance Technologies
23
Renaissance Technologies
New York
$335K +$276K +33,200 New
EAM
24
Exos Asset Management
New York
$210K +$173K +20,824 New
Two Sigma Investments
25
Two Sigma Investments
New York
$205K +$169K +20,364 New
1
2

ROIV Hedge Fund Activity: Q4 2021 in Review

42 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Roivant Sciences (ROIV) for Q4 2021, worth a combined $3.42B.

Buyers outnumbered sellers: 42 funds opened new ROIV positions and 0 closed out — a net gain of 42 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was QVT Financial, opening a new position worth an estimated $1.08B.

  • 42 institutional investors held Roivant Sciences (ROIV) as of Q4 2021, up from 0 in Q3 2021.
  • Funds reported $3.42B of Roivant Sciences stock for Q4 2021.
  • 42 funds opened new Roivant Sciences positions in Q4 2021 and 0 closed out, a net change of +42 holders.
  • The largest Roivant Sciences buyer in Q4 2021 was QVT Financial, an estimated $1.08B added.

Based on aggregated 13F filings for Q4 2021.